Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes
NCT: NCT07710989 · NOT_YET_RECRUITING
Brief Summary
Individuals with schizophrenia often experience persistent auditory hallucinations despite treatment with antipsychotic medications. Research suggests that abnormal communication between the striatum and the auditory cortex contributes to hallucinations. This first-in-human, proof-of-concept Phase 1 study will evaluate the safety, feasibility, and preliminary effects of repeated-session low-intensity focused ultrasound (LIFU), a non-invasive neuromodulation technique targeting the striatum. The study will examine whether LIFU can safely modulate brain circuits involved in hallucinations, reduce abnormal communication between the striatum and auditory cortex, and improve auditory hallucination symptoms.
Frequently Asked Questions
What is Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes?
Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes is a clinical trial registered under NCT07710989. Current status: NOT_YET_RECRUITING.
What is the status of NCT07710989?
The current status of NCT07710989 (Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes) is: NOT_YET_RECRUITING.
When did Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes start?
Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes started on 2027-02-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.